CM Life Sciences, Inc. Unit
CMLFU
CMLFU was delisted on the 22nd of July, 2021.
58 hedge funds and large institutions have $393M invested in CM Life Sciences, Inc. Unit in 2020 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHCM
Sachem Head Capital Management
New York
|
+$36.5M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$33.7M |
| 3 |
Millennium Management
New York
|
+$27.7M |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$26.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KC
51
KCL Capital
New York
| $209K | +$210K | +20,000 | New |
|
52
Walleye Trading
New York
| $188K | +$189K | +18,000 | New |
|
|
BFM
53
Boothbay Fund Management
New York
| $146K | +$147K | +13,966 | New |
|
|
VCM
54
Vivaldi Capital Management
Chicago,
Illinois
| $131K | +$132K | +12,511 | New |
|
|
PAM
55
Panagora Asset Management
Boston,
Massachusetts
| $129K | +$129K | +12,280 | New |
|
|
HP
56
Hound Partners
New York
| $52K | +$52.6K | +5,000 | New |
|
|
57
Millennium Management
New York
| $27.6K | +$27.7M | +2,632,318 | New |
|
58
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$2.1K | +200 | New |
|
|
VFA
59
Valeo Financial Advisors
Carmel,
Indiana
| $2K | +$2.37K | +225 | New |
|
CMLFU Hedge Fund Activity: Q3 2020 in Review
58 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences, Inc. Unit (CMLFU) for Q3 2020, worth a combined $393M.
Buyers outnumbered sellers: 58 funds opened new CMLFU positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sachem Head Capital Management, opening a new position worth an estimated $36.5M.
- 58 institutional investors held CM Life Sciences, Inc. Unit (CMLFU) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $393M of CM Life Sciences, Inc. Unit stock for Q3 2020.
- 58 funds opened new CM Life Sciences, Inc. Unit positions in Q3 2020 and 0 closed out, a net change of +58 holders.
- The largest CM Life Sciences, Inc. Unit buyer in Q3 2020 was Sachem Head Capital Management, an estimated $36.5M added.
Based on aggregated 13F filings for Q3 2020.